Somatic characteristics and cardiovascular risk factors in growth hormone deficiency: A randomized, double-blind, placebo-controlled study of the effect of treatment with recombinant human growth hormone

2004 ◽  
Vol 16 (5) ◽  
pp. 533-543 ◽  
Author(s):  
W. Bell ◽  
J.S. Davies ◽  
W.D. Evans ◽  
M.F. Scanlon ◽  
R. Mullen
Sign in / Sign up

Export Citation Format

Share Document